HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

Registos relacionados

• GLP-1 receptor agonists and cardiovascular outcome trials: An update
  Por: Eirini Andrikou, et al.
  Publicado em: (2019-11-01)
• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
  Por: Kristensen, SL, et al.
  Publicado em: (2019)
• An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
  Por: Mustafa Kılıçkap, et al.
  Publicado em: (2021-02-01)
• Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
  Por: Fatemeh Taktaz, et al.
  Publicado em: (2024-07-01)
• Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
  Por: Marta Seghieri, et al.
  Publicado em: (2018-11-01)